Presbyopia may start to affect your daily life and make it harder to see things up close. Find out when to consider ...

As you age, your vision can start to deteriorate, making it difficult to focus on nearby objects. This common condition, ...

LNZ100 is a single-use, once-daily eye drop containing aceclidine, a small molecule acetylcholine receptor agonist that causes miosis.

The NDA submission for the treatment of presbyopia is supported by the positive data results from the pivotal Phase 3 CLARITY study. Aceclidine is a new chemical entity in the United States and is not ...

(RTTNews) - LENZ Therapeutics, Inc. (LENZ) Monday said that the Food and Drug Administration (FDA) has accepted the company's new drug application for LNZ100 for the treatment of presbyopia.

India's drug regulatory agency has approved new eye drops that can help remove reading glasses in people who have presbyopia.

Lenz Therapeutics shares hit a new 52-week high during Monday's session. The company announced the FDA accepted its new drug ...

The eye drops were initially approved for treating presbyopia in adults, but this approval was suspended on September 10, by the Central Drugs Standard Control Organization (CDSCO) following what ...

These drops have been specially developed for people who have presbyopia, an eye-related condition that affects those above ...

LENZ Therapeutics said the submission for the treatment of presbyopia is supported by the positive data results from a Phase 3 study. Aceclidine is a new chemical entity in the U.S. and isn't approved ...

Contact lenses industry is projected to witness a CAGR of 6.5% during the period 2024-2032. This growth can be attributed to ...

Acquisition creates a leading, clinical-stage company focused on the development of gene therapy treatments for rare inherited retinal degenerations New OPGx-LCA5 Phase 1/2 6-month data demonstrate sa ...